[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626966":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":10,"locations":31,"responsibleParty":47,"collaborators":10,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":10,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":65,"overallStatus":67,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Samsung Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Drug coated balloon",null,"Patients receiving drug coated balloon angioplasty",[13],"Device: Drug coated balloon",{"label":15,"type":10,"description":16,"interventionNames":17},"Drug-eluting stent","Patients receiving drug-eluting stent implantation",[18],"Device: Drug-eluting stent",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":10},"DEVICE","Patients receiving drug coated balloon angioplasty for de novo coronary artery disease",[9],{"type":21,"name":15,"description":25,"armGroupLabels":26,"otherNames":10},"Patients receiving drug-eluting stent implantationfor de novo coronary artery disease",[15],[28],{"name":29,"affiliation":5,"role":30},"Ki Hong Choi, MD, PhD","PRINCIPAL_INVESTIGATOR",[32],{"facility":5,"status":10,"city":33,"state":10,"zip":34,"country":35,"countryCode":10,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Seoul","06351","South Korea",{"type":37,"coordinates":38},"Point",[39,40],126.9784,37.566,{"lat":40,"lon":39},[43],{"name":44,"role":45,"phone":46,"phoneExt":10,"email":10},"Ki Hong Choi","CONTACT","01088751648",{"type":30,"investigatorFullName":44,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Associate Professor","100626966","drug-coated-balloon-vs-drug-eluting-stent-in-patients-with-coronary-artery-disease-100626966",false,"NCT07442500","Drug Coated Balloon vs. Drug-eluting Stent in Patients With Coronary Artery Disease","DCB_DES","Inclusion Criteria:\n\n* Patients with coronary artery disease undergoing percutaneous coronary intervention\n* Used devices number less than three (relatively simple lesion)\n\nExclusion Criteria:\n\n* Hybrid strategy (DCB and DES use)\n* Failed percutaneous coronary intervention\n* Previous revascularization procedure before index percutaneous coronary intervention","ALL",{"count":58,"type":59},470000,"ESTIMATED","OBSERVATIONAL","Studies exploring the feasibility of drug-eluting balloon (DCB) in de-novo coronary lesions are limited. There are scarce data comparing DCB with drug-eluting stent (DES) in patients with high bleeding risk (HBR), a situation in which long-term maintenance of dual antiplatelet therapy (DAPT) is a clinical dilemma. This target trial emulation aims to compare clinical outcomes between DCB angioplasty and conventional DES implantation in de-novo coronary lesions in patients with coronary artery disease.",[63,64],"Coronary Artery Disease","Percutaneous Coronary Intervention (PCI)",[9,15,66],"High bleeding risk","NOT_YET_RECRUITING","2026-02-24",{"date":70,"type":71},"2026-03-02","ACTUAL",{"date":73,"type":59},"2026-02-28",{"date":75,"type":59},"2026-12-31",{"name":5,"class":6},1]